Four directions for the development of modern Chinese medicine in Shanghai

[China Pharmaceutical network industry trends 】On August 30, Shanghai released the implementation opinions of Shanghai on promoting the healthy development of biomedical industry, which clearly states that by 2020, Shanghai's innovation capacity of biomedical industry will maintain a national status, with its main business income reaching more than 380 billion yuan, and it will basically build a product R & D center, manufacturing center, outsourcing and service center and have the ability to allocate global resources in the Asia Pacific region Modern drug circulation system Biomedical industry is one of the five 10 trillion yuan pillar industries in the 13th five year plan for the development of national strategic emerging industries It is also a strategic emerging industry focused on the development of Shanghai The development of biomedical industry is of great significance to the optimization and upgrading of Shanghai's industrial structure and the cultivation of new driving forces for development In the 1990s, Shanghai maintained the position of the national pharmaceutical industry for a long time, but in recent years, the main business income ranking of the national pharmaceutical industry has fallen to the level of the middle reaches of China Nowadays, the leading position of Shanghai's national biomedical industry no longer exists, and the industrial development faces many challenges, such as the lack of leading enterprises, the outflow of a large number of innovative achievements, the lack of investment in research and development, and the difficulty of products entering the medical insurance Therefore, the biomedical industry in Shanghai needs to strengthen policy guidance, further cultivate and expand leading enterprises, accelerate industrial transformation and development, and encourage innovation and achievement promotion   According to the implementation opinions of Shanghai on promoting the healthy development of biomedical industry, Shanghai will enhance its independent innovation capacity, build a global biomedical innovation and R & D center, seize the historical opportunity of Shanghai to accelerate the construction of a science and technology innovation center with global influence, build large scientific and technological infrastructure such as transformation medical research center, and implement major scientific plans such as the international human phenotype group, We will promote the construction of functional platforms for biomedical technology and clinical research in Shanghai Shanghai will focus on key areas of advantage and build an internationally renowned biomedical product manufacturing center, including four major directions: giving priority to the development of biological products, focusing on the development of medical devices, continuously developing chemical drugs and promoting the development of modern Chinese medicine At the same time, Shanghai will cultivate new industrial forms, build biomedical R & D outsourcing and health service demonstration center, including promoting the pilot of drug listing license holder system, pilot medical device registration applicants in the pilot Free Trade Zone entrust Shanghai medical device manufacturing enterprises to produce products, etc Shanghai will build a highland of pharmaceutical chain supply, establish a modern pharmaceutical circulation system with the ability to allocate global resources, including carrying out the feasibility study of establishing an international pharmaceutical trading center, supporting the establishment of smart pharmaceutical supply chain demonstration enterprises and innovation demonstration bases, and improving the traceability system of the whole pharmaceutical supply chain In addition, Shanghai will strengthen the supporting and quality system, promote the agglomeration, transformation and healthy development of biomedical industry, including promoting intelligent production and construction demonstration, and strengthen the awareness of quality and safety responsible person of pharmaceutical enterprises We will guide industries to gather in relevant regions and promote the transformation of manufacturing industry into biopharmaceutical, pharmaceutical and medical devices Original title: Shanghai wants to regain its position in biomedicine: four directions for the development of modern Chinese Medicine